Showing results (201-210 of 465) with videos related to
Sort By:
Pageof 47
Sleep Medicine Reviews|January 30, 2013
Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medicationsAndrew D Krystal, Elliott Richelson, Thomas RothThe American Journal of Managed Care|December 6, 2007
The state of insomnia and emerging trendsThomas Roth, Meg Franklin, Thomas J BramleySleep & Breathing = Schlaf & Atmung|September 18, 2007
Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apneaThomas Roth, Gregory A Rippon, Sanjay AroraSleep|September 22, 2005
Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environmentThomas Roth, Charlene Stubbs, James K WalshSleep & Breathing = Schlaf & Atmung|February 13, 2007
Safety of ramelteon in individuals with mild to moderate obstructive sleep apneaMeir Kryger, Sherry Wang-Weigand, Thomas RothThe Journal of Clinical Psychiatry|April 23, 2010
An introduction to the clinical correlates of disrupted slow-wave sleepThomas Roth, Ruth M Benca, Milton ErmanSleep|November 2, 2012
Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled studySurilla Randall, Timothy A Roehrs, Thomas RothJournal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 30, 2020
Risk of excessive sleepiness in sleep restriction therapy and cognitive behavioral therapy for insomnia: a randomized controlled trialPhilip Cheng, David Kalmbach, Cynthia Fellman-Couture, et al.Sleep|July 1, 2022
The natural history of insomnia: high sleep reactivity interacts with greater life stress to predict the onset of acute insomniaJamie L Walker, Ivan Vargas, Christopher L Drake, et al.Sleep|September 20, 2019
Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trialPhilip Cheng, David A Kalmbach, Gabriel Tallent, et al.Pageof 47